Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Cost of Revenue (2020 - 2025)

Celularity (CELU) has disclosed Cost of Revenue for 6 consecutive years, with $3.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Cost of Revenue rose 0.54% to $3.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $20.0 million, a 9.62% decrease, with the full-year FY2024 number at $15.0 million, down 6.41% from a year prior.
  • Cost of Revenue was $3.9 million for Q3 2025 at Celularity, down from $5.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $14.5 million in Q4 2023 to a low of -$4.5 million in Q4 2022.
  • A 5-year average of $2.8 million and a median of $2.0 million in 2023 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: soared 1164.38% in 2021, then tumbled 1102.66% in 2022.
  • Celularity's Cost of Revenue stood at $451000.0 in 2021, then crashed by 1102.66% to -$4.5 million in 2022, then soared by 421.32% to $14.5 million in 2023, then plummeted by 49.46% to $7.3 million in 2024, then plummeted by 46.83% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Cost of Revenue are $3.9 million (Q3 2025), $5.2 million (Q2 2025), and $3.6 million (Q1 2025).